Penny Stocks

Traws Pharma Inc. (NASDAQ:TRAW) shares are trading lower on Monday as the company faces regulatory challenges regarding its influenza treatment program. The decline follows a recent update indicating that the planned Phase 2a human influenza challenge study for its lead compound, tivoxavir marboxil...

BLUF: A $3M AI deal sent INHD up 3,661%, but micro-cap AI speculation masks going-concern warnings, reverse splits, and dilution risk. Inno Holdings Inc. (NASDAQ:INHD) became one of 2026's most talked-about micro-cap stories on June 8, when its stock surged 3,661% in a single session, closing at $...

GT Biopharma Inc. (NASDAQ:GTBP) on Monday said its recently implemented artificial intelligence-based technologies are improving drug discovery productivity and pipeline development efficiency, with the company expecting additional development candidates to advance into pre-IND development in 2027...

BioLineRx Ltd (NASDAQ:BLRX) stock is trading lower on Tuesday, following the announcement of new data regarding their GLIX1 treatment, which demonstrates a potent anti-tumor effect in glioblastoma. GLIX1 Demonstrates Tumor Growth Inhibition BioLineRx, a commercial-stage biopharmaceutical company...

InMed Pharmaceuticals Inc. (NASDAQ:INM) shares are up during Tuesday’s premarket session, as the company announced a merger agreement with Mentari Therapeutics. The merger aims to combine Mentari’s innovative migraine prevention therapies with InMed’s public market capabilities,...

Beyond Meat Inc. (NASDAQ:BYND) shares were down after the company reported first-quarter results after Wednesday’s closing bell and guided for second-quarter revenue below the analyst estimate. Here's a look at the details inside the report.  BYND stock is moving. Watch the price...

Medicus Pharma Ltd. (NASDAQ:MDCX) on Wednesday reported expanded Phase 2 SKNJCT-003 study data showing a clear dose-response relationship for its Doxorubicin Microneedle Array (D-MNA or SkinJect) for nodular basal cell carcinoma (BCC). The company said the pre-specified analysis builds on...

Oncolytics Biotech, Inc. (NASDAQ:ONCY) shares are up on Monday as the company reported promising durability data for its investigational immunotherapy, pelareorep, in treating metastatic colorectal cancer. • Oncolytics Biotech shares are powering higher. What’s behind ONCY gains?...

Inno Holdings Inc. (NASDAQ:INHD) fell over 30% in after-hours trading on Wednesday following the company's announcement of a 1-for-20 reverse stock split aimed at maintaining compliance with Nasdaq listing requirements, particularly the minimum bid price rule. Reverse Stock Split Inno...

On Tuesday, Soligenix Inc. (NASDAQ:SNGX) said its pivotal Phase 3 FLASH2 trial evaluating HyBryte in cutaneous T-cell lymphoma (CTCL) will be halted after an interim analysis recommended stopping the study for futility, marking a setback for the late-stage biopharmaceutical company. The...

On Friday, Datavault AI Inc. (NASDAQ:DVLT) shares reversed earlier premarket gains and are now trading lower. Datavault AI 48,000-GPU Fleet Goes Live The cloud-based platform company announced that its 48,000-GPU fleet has come online, enhancing its capabilities in quantum-ready, high-performance...

Immutep Limited (NASDAQ:IMMP) shares are surging on Wednesday, up 100%, following the announcement that the company received FDA orphan drug designation for its product, eftilagimod alfa, in treating soft tissue sarcoma. Immutep is a clinical-stage biotechnology company developing novel...

Medicus Pharma Ltd. (NASDAQ:MDCX) on Wednesday said it will present new Phase 1 clinical data for its investigational therapy Teverelix at the American Association of Clinical Endocrinology Annual Meeting 2026. It will highlight early evidence supporting its long-acting profile and potential use...

Hoth Therapeutics Inc. (NASDAQ:HOTH) shares are up on Tuesday as the company reported positive data from its HT-VA study, which highlights the potential of GDNF as a next-generation therapy for metabolic-associated fatty liver disease (MAFLD). Hoth Therapeutics Candidate Shows Impact On Fat...